Letter to the EditorLoss of retinal function in aged DBA/2J mice – New insights into retinal neurodegeneration
Introduction
The DBA/2J mouse is a widely used inbred strain in cardiovascular biology, neurobiology, and sensorineural research, as well as for the pigment dispersion glaucoma, where pigment particles that normally are located on the iris get loose and distribute inside the anterior chamber (John et al., 1998). Pigment dispersion and iris atrophy were observed in DBA/2J mice usually at an age of six to eight months (John et al., 1998, Libby et al., 2005).
As a consequence of the glaucoma developing in DBA/2J mice, the nerve fibre layer becomes thinner, and the number of RGC is greatly depleted, accompanied by optic nerve atrophy and disorganisation (John et al., 1998). The majority of mice suffer increase of IOP, loss of RGC and optic nerve atrophy by 22 months of age (Jakobs et al., 2005, Libby et al., 2005, Schlamp et al., 2006). This consistency in glaucoma development in DBA/2J mouse makes this strain a useful tool to study this disease (Schuettauf et al., 2002).
The clear-cut way to determine functional loss in the case of RGC loss is to measure visual evoked potentials (VEP). However, no studies are published so far where VEP measurements were applied to study loss of RGC function in DBA/2J mice.
Therefore, we examined two-year-old DBA/2J mice that can be considered a kind of “end-point” regarding the degeneration process caused by the disease. Our aim was to evaluate the extent of RGC degeneration in such old DBA/2J mice, and we were interested whether visual function on both retinal and cortical levels could still be recorded. For this purpose, we performed Ganzfeld ERG and VEP measurements in aged DBA/2J mice and age-matched C57BL/6J mice as a control strain and labelled RGC retrogradely to quantify them.
Section snippets
Materials and methods
All mice were handled according to German animal protection laws, and all experiments were conducted in accordance with the Association for Research in Vision and Ophthalmology. DBA/2J and C57BL/6J mice were obtained from the European distributor of Jackson Laboratories mice (Charles River Laboratories) and were bred here for a maximum of two generations. All mice were kept under specific pathogen-free conditions at room temperature in a 12 h light/12 h dark cycle. For the DBA/2J strain, a
Results
In the electroretinographic waveforms obtained in aged DBA/2J mice and age-matched C57BL/6J mice, a clear impairment of retinal function in DBA/2J mice can be recognised at first sight; all waveforms of DBA/2J mice show considerably smaller amplitudes, as shown for scotopic ERG in Fig. 1A.
Numerical evaluation of the ERG parameters shows that amplitudes of a-waves are significantly smaller in DBA/2J mice at light intensities above 0.01 cd·s/m2 (p ≤ 0.027), and the same is true for the amplitudes
Discussion
We found a dramatically decreased number of RGC in retinal whole-mounts of aged DBA/2J mice, in an extent that the retina was almost devoid of RGC. Already in one year-old DBA/2J mice, Jakobs et al. (2005) observed severe loss of RGC by retrograde labelling, with large areas of the retina completely devoid of RGC.
Moreover, visual evoked potentials in the old DBA/2J mice were extremely reduced. It was difficult to determine the values of the VEP amplitudes at all in several of the aged DBA/2J
Conclusion
As a summarising conclusion, we investigated visual function in two-year-old DBA/2J mice. There were only weak visual evoked potentials recordable, which was not surprising given the extremely low number of RGC found in the retina. However, also flash ERG amplitudes were decreased clearly. Whether only the function of photoreceptors is impaired or if there are also structural deficits in the photoreceptors of old DBA/2J mice, remains to be elucidated.
Acknowledgements
The authors thank the Else Kröner-Fresenius-Stiftung (P40/08//A32/08) for supporting Sven Schnichels. Jan Kremers (Department of Ophthalmology, University Hospital Erlangen, University of Erlangen–Nuremberg) is acknowledged for critically reading the manuscript. All authors disclose any commercial interest in the subject of the manuscript or in entities discussed in the manuscript.
References (20)
- et al.
Gene expression of the repulsive guidance molecules/neogenin in the developing and mature mouse visual system: C57BL/6J vs. the glaucoma model DBA/2J
Gene Expr. Patterns
(2007) - et al.
Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model
Vis. Res.
(2002) - et al.
A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy
Brain
(2007) - et al.
Electrophysiological deficits in the retina of the DBA/2J mouse
Doc. Ophthalmol.
(2009) - et al.
Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy
Invest. Ophthalmol. Vis. Sci.
(2010) - et al.
Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave
Invest. Ophthalmol. Vis. Sci.
(1994) - et al.
Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma
J. Cell. Biol.
(2007) - et al.
Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice
J. Cell. Biol.
(2005) - et al.
Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice
Invest. Ophthalmol. Vis. Sci.
(1998) - et al.
Primary open angle glaucoma is not associated with photoreceptor loss
Invest. Ophthalmol. Vis. Sci.
(1995)
Cited by (42)
Retina in a dish: Cell cultures, retinal explants and animal models for common diseases of the retina
2021, Progress in Retinal and Eye ResearchCitation Excerpt :However, since glaucoma is a chronic disease, these acute crush models or axotomy models often fail to mimic the chronic pathways of glaucoma but are useful for studies of neuronal survival, neuroprotection and -regeneration. The DBA/2J mouse, as a genetic model, is probably the most commonly used mouse model in glaucoma research (Heiduschka et al., 2010; John et al., 1998; Libby et al., 2005; Schnichels et al., 2007; Schuettauf et al., 2004; Wang and Dong, 2016). However, this model reflects pigment dispersion glaucoma, a form of secondary glaucoma representing only 1–1.5% of glaucoma patients (John et al., 1998; Schraermeyer et al., 2009).
Inducible rodent models of glaucoma
2020, Progress in Retinal and Eye ResearchCitation Excerpt :RGC numbers and axonal transport function can be determined using intravitreal injection of cholera toxin B (CTB) attached to a fluorescent dye for anterograde transport or injection of a membrane impermeable fluorescent dye (e.g. diI, fluorogold) into the superior colliculus to measure retrograde transport. Optic nerve function also can be measured in vivo by recording light-induced electric currents in the visual cortex using visual evoked potentials (VEPs) (Domenici et al., 2014; Heiduschka et al., 2010; Porciatti et al., 1999). Histological damage to the ON can be assessed by counting axons, using either manual or automated imaging techniques (Ebneter et al., 2012; Oglesby et al., 2012; Quigley et al., 2011; Zarei et al., 2016).
Potential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma
2019, Brain Research BulletinCitation Excerpt :In addition, an increase of P2X7R was observed in OPL accompanied by a diminished synaptic connectivity in older animals. Increased levels of P2X7R were detected in synaptic terminal suggesting the possible apoptotic processes involved due to the impairment of retinal circuitry (Puthussery et al., 2006; Heiduschka et al., 2010). This result is in agreement with previous morphological findings where a loss of synaptic contacts in the OPL in an aging-dependent manner was observed in this model (Fernandez-Sanchez et al., 2014).
Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice
2017, Molecular Therapy Methods and Clinical DevelopmentRetinal neurodegeneration in experimental glaucoma
2015, Progress in Brain ResearchCitation Excerpt :Overall, our findings using molecular (Cuenca et al., 2010; Ortín-Martínez et al., 2015), functional (Salinas-Navarro et al., 2009c), and morphological (Cuenca et al., 2010; Ortín-Martínez et al., 2015; Salinas-Navarro et al., 2009c) studies document that following OHT, there is an important degeneration of the outer nuclear and outer segment retinal layers. Our results are in agreement with previous reports showing that OHT also results in adverse effects on the cone photoreceptor population: (i) in rodent models analyzed with morphometric techniques (Abbott et al., 2014; Fernández-Sánchez et al., 2014; Fuchs et al., 2012; Guo et al., 2010; Rojas et al., 2014), with functional techniques (Chen et al., 2015; Georgiou et al., 2014; Heiduschka et al., 2010; Mittag et al., 2000; Pérez de Lara et al., 2014), or with both (Bayer et al., 2001; Calkins, 2012); (ii) in monkey OHT models analyzed with anatomical techniques (Nork, 2000; Nork et al., 2000) or with functional techniques (Liu et al., 2014; Nork et al., 2014); and (iii) in human GONs analyzed with functional (Barboni et al., 2011; Bessler et al., 2010; Drasdo et al., 2001; Holopigian et al., 1990; Kanis et al., 2010; Niwa et al., 2014; Velten et al., 2001; Werner et al., 2011) or anatomical (Choi et al., 2011; Kanis et al., 2010; Lei et al., 2008, 2011; Nork, 2000; Nork et al., 2000; Panda and Jonas, 1992; Werner et al., 2011) techniques. The above reviewed results appear to be in contrast with previous studies that have not found cone photoreceptor loss in OHT monkey (Wygnanski et al., 1995) or human (Kendell et al., 1995) retinas.